Ali Elbireer

Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4⁺Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings

David B. Meya, Yukari C. Manabe, Barbara Castelnuovo et al. · Clinical Infectious Diseases · 2010 · 300 citations · Full text

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Nicholas I. Paton, Cissy Kityo, Immaculate Nankya et al. · The Lancet HIV · 2017 · 79 citations · Full text

The Good, the Bad, and the Unknown: Quality of Clinical Laboratories in Kampala, Uganda

Ali Elbireer, J. Brooks Jackson, Hakim Sendagire et al. · PLoS ONE · 2013 · 59 citations · Full text

Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy

Yukari C. Manabe, Yaping Wang, Ali Elbireer et al. · PLoS ONE · 2012 · 58 citations · Full text

Scaling up <scp>HIV</scp> viral load – lessons from the large‐scale implementation of <scp>HIV</scp> early infant diagnosis and <scp>CD</scp>4 testing

Trevor Peter, Clement Zeh, Zachary Katz et al. · Journal of the International AIDS Society · 2017 · 47 citations · Full text